Article
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer
22 Mar 2025
Abstract excerpt
BACKGROUND: Recurrent/metastatic head and neck squamous cell carcinoma (R/M-HNSCC) is a severe, frequently lethal condition. Oncogene addiction to epidermal growth factor receptor (EGFR) is a hallmark of HNSCC, but the clinical efficacy of EGFR-targeted therapies remains low. Understanding molecular networks governing EGFR-driven progression is paramount to the exploration of (co)-treatment targets and predictive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
